Taking advantage of this technique, we analyzed a series of lymphoblastoid patient cell lines, i.e., immortalized lymphocytes, with defined mutations in various breast and ovarian cancer predisposing genes including BRCA1, BRCA2, TP53, and ATM [140–142]. This evidence concerns the gene TP53 and ovarian cancer.